Physician profile
Shayna Manuel
NPI 1710385158
$2,040.16
in general payments reported to CMS, 2019-2025
18 companies · $604 in 2025
The $604 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $91.88 · 2023: $827 · 2024: $517 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,583 · Education: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,583.30 |
| Education | $364.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $537.23 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $426.90 | 2023-2025 | |
| Exeltis, USA INC. | $360.40 | 2022-2025 | Slynd |
| Abbvie INC. | $87.14 | 2022-2025 | |
| Hologic Sales and Service, LLC | $77.00 | 2023-2025 | Aptima |
| Myriad Women'S Health, INC. | $75.23 | 2023 | Myrisk |
| Millicent US INC | $74.28 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Shield Therapeutics INC | $70.58 | 2023-2024 | Accrufer |
| Organon LLC | $70.19 | 2023-2024 | Nexplanon |
| Biogen, INC. | $68.26 | 2025 | Zurzuvae |
| Takeda Pharmaceuticals U.S.A., INC. | $42.44 | 2023 | Vpriv |
| Aspira Women'S Health INC | $29.51 | 2024 | Ova1 |
| Sumitomo Pharma America, INC. | $26.30 | 2023 | Myfembree |
| Pfizer INC. | $25.14 | 2025 | |
| Novo Nordisk INC | $19.26 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $19.23 | 2022 | |
| Avion Pharmaceuticals | $15.83 | 2023 | Balcoltra |
| Pharmacosmos Therapeutics INC. | $15.24 | 2023 | Monoferric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shayna Manuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.